Highland Capital Management (Tennessee)’s Quest Diagnostics DGX Stock Holding History

Highland Capital Management (Tennessee)’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-31,145	Closed	-$3.46M	–	354
2017 Q2	$3.46M	Buy	31,145 +20	+0.1%	+$2.12K	0.28%	115
2017 Q1	$3.06M	Sell	31,125 -270	-0.9%	-$25.7K	0.25%	114
2016 Q4	$2.88M	Sell	31,395 -278	-0.9%	-$24K	0.24%	113
2016 Q3	$2.68M	Sell	31,673 -2,255	-7%	-$189K	0.23%	120
2016 Q2	$2.76M	Sell	33,928 -23,842	-41%	-$1.82M	0.24%	114
2016 Q1	$4.13M	Sell	57,770 -395	-0.7%	-$26.5K	0.35%	90
2015 Q4	$4.14M	Buy	58,165 +3,090	+6%	+$208K	0.33%	94
2015 Q3	$3.38M	Sell	55,075 -430	-0.8%	-$30.1K	0.28%	112
2015 Q2	$4.03M	Buy	+55,505	New	+$4.1M	0.31%	97

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Highland Capital Management (Tennessee)'s DGX Position: Q3 2017 in Review

Highland Capital Management (Tennessee) sold out of Quest Diagnostics (DGX) in Q3 2017, closing a stake of 31,145 shares — an estimated $3.46M sold.

Highland Capital Management (Tennessee) first reported a position in DGX in Q2 2015 and held it in 9 quarters. The position peaked at $4.14M in Q4 2015. 616 funds tracked by Wall St. Rank hold DGX as of Q3 2017.

Highland Capital Management (Tennessee) reported no remaining Quest Diagnostics position as of Q3 2017 after selling out during the quarter.
Highland Capital Management (Tennessee) sold 31,145 Quest Diagnostics shares in Q3 2017, an estimated $3.46M.
Highland Capital Management (Tennessee) first reported a position in Quest Diagnostics in Q2 2015 and held it in 9 quarters.
Highland Capital Management (Tennessee)'s Quest Diagnostics position peaked at $4.14M in Q4 2015.
616 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2017.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q3 2017, filed 10 Oct 2017.